#49 Obesity and CKD, with Marieta Theodorakopoulou

Update: 2025-09-11

Description

Marieta Theodorakopoulou reveals why excess weight is a silent but powerful driver of chronic kidney disease. With obesity rates soaring, especially among younger generations, she guides us through the mechanisms of obesity-associated renal lesions, how to tailor treatments for obese CKD patients, and what we know about the renal safety of anti-obesity drugs.

Comments

In Channel

Trailer Primary hyperoxaluria type 1, Antibody-mediated rejection treatment – now and in the future and Sustainable nephrology

2025-10-0202:05

#51 Monoclonal gammopathy with renal significance, with Jolanta Małyszko

2025-09-1128:47

#50 Onconephrology: A huge subject, with Kenar D. Jhaveri

2025-09-1115:48

#49 Obesity and CKD, with Marieta Theodorakopoulou

2025-09-1123:17

Trailer Obesity and CKD, Onconephrology: A huge subject and Monoclonal gammopathy with renal significance

2025-09-0401:52

#48 Xenotransplantation: Is it for real? with David Cooper

2025-06-1931:01

#47 Infection prophylaxis for renal transplant recipients in 2025, with Ilaria Gandolfini

2025-06-1928:27

#46 Adapting anti-rejection treatment in a failing renal graft, with Cristophe Mariat

2025-06-1915:43

Trailer Adapting anti-rejection treatment in a failing renal graft, Infection prophylaxis for renal transplant recipients in 2025 and Xenotransplantation: Is it for real?

2025-06-1202:29